
doi: 10.17826/cutf.49433
Amac: Talasemi ve orak hucreli anemi hastalari sik transfuzyon almaktadir. Hepatit B (HBV), hepatit C (HCV) ve insan immun yetmezlik virusu (HIV) kanla gecmektedir. Bu calismanin amaci hemoglobinopati hastalarimizda bu enfeksiyonlarin sikligini belirlemektir. Materyal ve Metod: Dort yuz on hemoglobinopati hastasini inceledik.Viral serolojiler "ikinci jenerasyon enzim baglantili immun absorban tahlil" metoduyla incelendi. Dort yuz on hastanin (116 talasemi major, 16 talasemi intermedia, 12 hemoglobin H, 222 orak hucreli anemi, 43 orak-beta talasemi ve 1 Hb E) 258"i erkek, 152"si kadindi. Bulgular: HBV sikligi %1,2, HCV %3,2 ve HIV %0 bulundu. Sonuclarimiz gostermektedir ki transfuzyon iliskili viral enfeksiyon sikligi literature kiyasla daha yuksek degildir. Sonuc: Peryodik olarak duyarli tarama testlerinin kullanilmasi ve dogru verici secimi yuksek risk altindaki hemoglobinopati hastalarinin bu enfeksiyolarda korunmasinda cok onemlidir.
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
